AI is rapidly transforming the landscape of clinical research, offering promising avenues to overcome longstanding challenges in clinical trials. A recent article in JAMA Cardiology, highlighted in an editorial in JAMA, delves into the potential of AI, particularly NLP, to revolutionize clinical trials, a sector currently burdened by high cost. |